Dr. Ruby Srivastava, CSIR-CCMB, Hyderabad, India
Dr. Ruby Srivastava is an accomplished Indian scientist with expertise in computational chemistry, bioinformatics, optoelectronics, and AI-integrated biomedical research. With over 30 research publications (including 18 solo-authored papers) and 6 published books, she has demonstrated a strong academic foundation and remarkable research leadership. Her work bridges physics, chemistry, biology, and artificial intelligence, making her a truly interdisciplinary scientist.
Profile
Google scholar
Orcid
🎓 Early Academic Pursuits
Dr. Srivastava began her journey with a Master’s in Physics (Electronics) from the University of Lucknow (1992–1994), laying a strong technical foundation. She later earned her Ph.D. (2005–2010) in Physics from the same institution, focusing on the conformational study of natural products, integrating chemistry and biophysics from an early stage. This academic combination positioned her uniquely at the intersection of theoretical modeling and applied sciences.
🧪 Professional Endeavors
Dr. Srivastava has over two decades of professional engagement across academia, government-funded research, and interdisciplinary collaborations. She has held positions as a principal investigator and co-investigator on major projects funded by the Department of Science and Technology (DST), India, accumulating project funding exceeding ₹1.6 crore INR.
Her affiliations span premier institutions such as:
-
CSIR-IICT, Hyderabad
-
Centre for Cellular and Molecular Biology (CSIR-CCMB)
-
Indian Institute of Technology (IIT), Powai, Mumbai
🔬 Contributions and Research Focus
Dr. Srivastava’s research spans quantum mechanics/molecular mechanics (QM/MM), density functional theory (DFT), coinage metal clusters, OLEDs, DSSCs, and RNA-based biomedical applications. Her recent pivot to reverse vaccinology and mRNA vaccine design aligns with global biomedical priorities.
Notably, her theoretical investigation on Iridium(III) complexes in OLEDs and nanoclusters was ranked #1 among top 20 papers by major publishers in the field — an extraordinary recognition of the depth and innovation of her work.
🌍 Impact and Influence
With numerous publications in reputed journals such as PCCP, Computational and Theoretical Chemistry, and ACS Omega, Dr. Srivastava has earned a place among the Top 0.1% most-read authors on Academia.edu. She is also a reviewer for over 25 international journals, contributing significantly to the global peer-review ecosystem.
📈 Academic Citations and Scientific Recognition
While specific citation indices like h-index or i10-index were not provided, her wide journal engagement, reviewer invitations, and international editorial role (as Review Editor for Frontiers in Physics) reflect recognition and trust from the broader academic community. She has been nominated for Longuet-Higgins Early Career Researcher Prize (2016, 2018) and invited for prestigious awards such as the Exceptional Scientist Award (AAAS).
🧠 Research and Technical Skills
Dr. Srivastava consistently upgrades her skills. She holds certifications in:
-
Python, R, SQL, and AI/ML tools
-
Quantum computing (Amazon Braket, Cloud QC Essentials)
-
Bioinformatics and SAS for Pharma
-
Scientific Communication and Peer Review Excellence
She has completed 40+ professional short courses through platforms like LinkedIn Learning, Datacamp, ACS, and Springer Nature, demonstrating her commitment to lifelong learning and translational skill application.
👩🏫 Teaching Experience
With over 15 years of teaching experience at the graduate and postgraduate level in Physics (1994–2009), Dr. Srivastava is deeply rooted in academic mentorship. Her ability to integrate theoretical rigor with applied science makes her a valuable mentor. Currently, she mentors honorary student Sravani Joshi, and more formal mentorship would significantly add to her academic legacy.
🏆 Awards and Honors
Dr. Srivastava’s accolades include:
-
Top 0.1% most-read author on Academia.edu
-
ACS Reviewership Certificate (2018)
-
Quarterly Franklin Membership by LJRS
-
Invitations for major international science awards
These honors reflect both research impact and peer recognition, further validating her standing in the academic and research ecosystem.
📚 Books and Science Communication
She has authored/edited six published books and submitted a seventh manuscript on DFT and DFT-ML hybrid methods — covering themes such as:
Her works are published by Cambridge Scholars Publishing, CRC Press, IntechOpen, and Bentham Science, establishing her as a thought leader in scientific publishing.
🧭 Legacy and Future Contributions
With a rich combination of research acumen, technical expertise, and educational grounding, Dr. Ruby Srivastava is positioned to make continued global contributions in computational chemistry, AI-integrated biology, and vaccine technology.
Her next frontier appears to be mRNA vaccine design and RNA-targeted therapeutics, combining quantum modeling and AI/ML — areas with profound global health and pharmaceutical potential. Her proactive learning in AI tools, cloud quantum platforms, and bioinformatics integration suggests a future-ready scientific vision.
Top Publications
Effect of “magic chlorine” in drug discovery: an in silico approach
- Authors: Sravani Joshi, Ruby Srivastava*
Journal: RSC Advances
Year: 2023
Tracing the pathways and mechanisms involved in medicinal uses of Flaxseed with computational methods and bioinformatics tools
- Authors: Sravani Joshi, Ruby Srivastava*
Journal: Frontiers in Chemistry
Year: 2024
Physicochemical properties and biological efficacy of 30 DYRK2 Inhibitors for the Treatment of Prostate Cancer
Biological Efficacy of 40 Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Study
- Authors: Sravani Joshi, Ruby Srivastava*
Journal: Iranian Journal of Science
Year: 2024
Theoretical studies on Safety and Efficacy of 16 Small-molecule MC4R antagonists as therapeutics for Obesity
- Authors: Sravani Joshi, Ruby Srivastava*
Journal: Journal of Proteins and Proteomics
Year: 2025